
Sign up to save your podcasts
Or


On this week’s Tech Nation, learning to draw on the radio! Dan Roam, the founder of The Napkin Academy, invites us to make simple drawings showing what the COVID-19 pandemic looks like to each of us. They’ll also talk about his writer’s workshop and how he’s writing his upcoming book– “The Pop-Up Pitch” – he’s inviting all nonfiction writers to write their books along with him.
On this week’s Tech Nation, Ohio State University professor Angus Fletcher connects neuroscience and literature, and why stories can be so compelling – from Greek tragedy to modern times. His book is “Wonderworks … the 25 Most Powerful Inventions in the History of Literature”. Then a ten-minute primer with David Peterson, best known for creating alien languages for HBO’s Game of Thrones, Netflix's The Witcher, and Marvel's Doctor Strange.
On this week’s Tech Nation, Dr. Jonathan Javitt from NeuroRX Pharma talks about a scientific discovery which lingered for nearly two decades in some 70 boxes in deep storage – it’s now being tested as a treatment for COVID-19. Then Rick Carreon, the CEO of ImpediMed, tells us about a technology developed in the 1990’s for research purposes. Today it’s approved for the early detection of lymphedema following breast cancer – and early intervention can stop its progression.
On this week’s Tech Nation, Wharton Marketing Professor, Jonah Berger, follow his earlier books, “Contagious” and “Invisible Influence”. His latest is “The Catalyst – How To Change Anyone’s Mind”. Then on BioTech Nation, using viruses to our benefit. That’s the idea from Aspa Therapeutics. Dr. Eric David described Aspa’s approach to deliver essential treatment for the rare genetic condition of Canavan’s Disease.
On this week’s Tech Nation, Moira speaks with Dr. Greg Frost, the CEO of Exuma Biotech. He explains how gene therapy for cancer is currently a 6 to 8 week proposition, and requires the patient to undergo chemotherapy. Exuma’s aim is to reduce the time to 4 hours and eliminate the chemotherapy …
Then Dr. Chris Smith with Brandon Capital Partners and a board member of Ena Respiratory talks about updates us on Ena-51 – a spray to reduce the presence of COVID in the nasal passageway.
From the publisher's feed
TechNation Radio hosted by Dr Moira Gunn

21,775 Listeners

43,845 Listeners

31,921 Listeners

37,863 Listeners

6,806 Listeners

43,374 Listeners

26,797 Listeners

2,855 Listeners

9,172 Listeners

465 Listeners

725 Listeners

924 Listeners

6,430 Listeners

939 Listeners

18 Listeners